Rainbow Children's Medicare Ltd. Share Price

Overview

Rainbow Children's Medicare Ltd. share price is currently ₹1,156.93, down by - ₹22.01 (1.87%) from its previous closing price of ₹1,178.94. The share price has declined -18.49% over the past month and declined -11.13% over the past year. The stock's 52-week low and high are ₹1,069.98 and ₹1,597.81, respectively. Rainbow Children's Medicare Ltd. has a market capitalisation of ₹ 12,630.00 Cr. The share price was last updated on 23 Oct 2026, 03:29 PM IST.

Rainbow Children's Medicare Ltd.
Rainbow Children's Medicare Ltd.
RAINBOW
 ₹0.00
- ₹22.01
1.87%
Healthcare
 ₹0.00(%)1D

Updated: 23 Oct 2026, 03:29:57 pm IST

Market Data

Open Price

 ₹1,187.31

Prev. Close

 ₹1,178.94
 ₹1,144.15

Day Low

 ₹1,196.94

Day High

 ₹1,069.98

52 Week Low

 ₹1,597.81

52 Week High

HealthcareHospital & Healthcare Services
CategorySmall Cap

Fundamentals

Quick Bite

Price To Earnings Ratio

41.17

Sector PE

42.08

PB Ratio

7.15

Sector PB

5.48

EPS

28.10

Dividend Yield

0.30

Today's Volume

79.734 K

5 Day Avg. Volume

129.329 K

PEG Ratio

2.87

Market Cap.

₹ 12,630.00 Cr.

StockGro Trade views

Technical Analysis

Forecasts 🧭

Financials

Corporate Actions

ActionsEx-DateRecord-Date
DividendsFinal Dividend of 35% at ₹3.5/Share
21-Jul-202621-Jul-2026
DividendsFinal Dividend of 30% at ₹3/Share
27-Jun-202528-Jun-2025

Mutual Fund Ownership

Mutual Fund Holder
Aug 26
Shares held
Sep 26
Shares held
ICICI Prudential Large & Mid Cap Fund - Growth24.46 Lac
21.61 Lac
(11.63%)
DSP Small Cap Fund - Regular Plan - Growth15.37 Lac
15.37 Lac
no change
Motilal Oswal Small Cap Fund - Regular Plan - Growth13.85 Lac
14.90 Lac
(7.56%)
ICICI Prudential Multi Asset Allocation Fund - Growth13.47 Lac
13.38 Lac
(0.66%)
Axis Small Cap Fund - Regular Plan - Growth10.63 Lac
10.63 Lac
no change

About Rainbow Children's Medicare Ltd. 👋

Rainbow Children's Medicare Limited is an India-based company, which is engaged in the business of rendering medical and healthcare services. The Company is a multi-specialty pediatric and obstetrics and gynecology hospital operating across approximately 20 hospitals and five outpatient clinics, spread across seven Indian cities, with a capacity of 2,035 beds. It offers pediatric services under Rainbow Children's Hospital, which include newborn and pediatric intensive care, pediatric multi-specialty services and pediatric quaternary care (including multi-organ transplants). Its women care services under Birthright by Rainbow that offers perinatal care services, which include normal and complex obstetric care, multi-disciplinary fetal care, perinatal genetic and fertility care, along with gynecology services. It also operates pediatric Diplomate of National Board (DNB) training programs in private healthcare, offering post-graduate residential DNB and fellowship programs.

Expert Opinions

Insights from SEBI-registered analysts · updated live

Explore all →
SASI KUMAR SEBI RA

SASI KUMAR SEBI RA

20 Oct • 1:10 PM · SEBI-Registered Analyst

Healthcare Stocks for a Long-Term Watchlist

Healthcare demand does not depend entirely on how the stock market performs. People need medical treatment in good and bad economic conditions. Rising incomes, wider insurance coverage and higher spending on healthcare can support the sector over time. Here are 7 listed healthcare companies to study for a long-term watchlist: • Apollo Hospitals • Max Healthcare • Fortis Healthcare • Narayana Health • KIMS • Rainbow Children’s Medicare • Aster DM Healthcare Before investing, compare each company’s valuation, revenue growth, debt, margins and expansion plans. A growing sector does not mean every stock is available at the right price. Not a buy/sell recommendation. For educational purposes only.

See More
Ashish Kumar

Ashish Kumar

3 Oct • 4:01 PM · SEBI-Registered Analyst

Supreme Court Scrutiny on Medicine Mark-ups

Hospital stocks remain in the spotlight after the Supreme Court raised sharp concerns over steep mark-ups on medicines sold to patients at private hospitals. A bench flagged a cancer drug supplied to retailers at around ₹2,700 but carrying an MRP of ₹27,000 — nearly a tenfold difference — and questioned why the existing 16% trade margin cap on scheduled drugs has not been extended to non-scheduled medicines that dominate the market. The court also directed the Centre to examine practices compelling patients to buy from in-house or designated hospital pharmacies. The matter is listed for further hearing on October 12. The remarks triggered a sharp sell-off, with the BSE Hospitals Index falling about 5% and chains such as

MAXHEALTH
Healthcare, KIMS and others declining 5-6%. Brokerages have assessed the potential earnings hit. Goldman Sachs estimates a 2-7% EBITDA impact in scenarios with no mitigation, though it notes that modest pricing adjustments or greater use of package billing could cushion the effect. Emkay remains constructive on the sector, assigning Buy ratings to KIMS (target ₹850) and Park Medi World, and Add ratings to Max Healthcare (₹1,150), Global Health/Medanta (₹1,500) and Rainbow Children’s Medicare (₹1,550).

See More
Pyrifera Investment Advisors

Pyrifera Investment Advisors

30 Sep • 6:01 PM · SEBI-Registered Analyst

Rainbow Childrens secures 250-bed Amaravati hospital lease

Rainbow Childrens secured a 60-year lease for 2 acres in Amaravati to build a 250-bed super speciality hospital. This expands its existing 2,565-bed network by nearly 10% while maintaining an asset-light, debt-free balance sheet. The agreement with the Andhra Pradesh Capital Region Development Authority establishes a greenfield hub in the upcoming capital region. This matters because it creates a dense maternal and pediatric care network alongside existing Vijayawada and Guntur facilities, driving regional market share. I am watching the construction milestone updates and the expected 18-to-24-month operational break-even timeline, specifically tracking Q3 FY27 capex deployment metrics for this project. The market often penalizes healthcare stocks for greenfield capex, fearing prolonged gestation periods and margin drag. What the consensus misses is the structural advantage of Rainbow’s lease-based expansion model. Unlike peers that take on heavy debt to acquire land, this 60-year lease preserves the company's pristine balance sheet. Capital is allocated strictly to high-ROI medical equipment and fit-outs, avoiding sunk land costs. By clustering this new facility within the Guntur-Vijayawada-Amaravati tri-city corridor, Rainbow achieves immediate operational synergies, shared specialist doctor pools, and centralized supply chain efficiencies. The market prices this as a standard capacity addition, ignoring the superior capital efficiency and faster path to profitability that this specific geographic clustering guarantees. Accumulate for long-term, capital-efficient capacity growth. Disclosure: I do not hold positions in this stock. This is for educational purposes only and does not constitute investment advice.

RAINBOW

See More
TrueNorth Capital

TrueNorth Capital

4 Sep • 12:00 PM · SEBI-Registered Analyst

Rainbow Children’s Medicare: Scaling Up for the Next Phase

RAINBOW
plans to add approximately 2,500 beds over the next five years, doubling its total capacity to roughly 5,000 beds while management targets near-term revenue growth exceeding 20%. Robust Q1 FY27 Performance: Revenue grew 33% year-over-year to ₹470 crore with EBITDA rising 30% to ₹135 crore (28.6% margin). This operational momentum was driven by significant volume gains, including a 28% increase in inpatient discharges and a 25% rise in outpatient consultations. Temporary Margin Headwinds: EBITDA margins are expected to moderate to the 24–25% range for FY27 as newly commissioned facilities incur upfront fixed operating costs ahead of optimal capacity utilization. Shift to Capacity Monetisation: With major expansion cycles maturing, focus is transitioning from adding infrastructure to raising bed occupancy, creating operational leverage where incremental volumes boost EBITDA disproportionately. Strong Financial Foundations: Supported by ₹613 crore in cash and liquid reserves, Rainbow maintains a resilient balance sheet capable of funding future growth without compromising financial flexibility. Attractive Valuation & Industry Tailwinds: Positioned in the specialized pediatric and maternity care sector, Rainbow benefits from rising healthcare demand and currently trades at ~20x FY28e EV/EBITDA, representing a compelling entry point below historical averages.

See More
Pavan Rawat

Pavan Rawat

26 Aug • 2:33 PM · SEBI-Registered Analyst

RAINBOW CHILDREN SHARES FALL ON CFO RESIGNATION

RAINBOW
Shares of Advait Energy Transitions gained 4% after the company received a turnkey contract worth ₹134.63 crore from Madhya Pradesh Power Transmission Co. Ltd. The order involves the design, manufacturing and supply of an Emergency Restoration System suitable for 400kV, 220kV and 132kV voltage-class extra-high-voltage transmission lines, along with all associated accessories. Sai Parenterals shares rose nearly 3% after its Australian subsidiary, Noumed Pharmaceuticals, renewed its OTC Medicines Supply Agreement with one of Australia’s leading multi-billion-dollar pharmacy chains. The renewed agreement includes an expanded product portfolio, a longer tenure and a higher contract value. The deal is estimated at AUD 30 million, or approximately ₹204 crore, over a three-year period and is effective immediately. Rainbow Children’s shares declined nearly 2% after the company announced that Vikas Maheshwari had resigned as Chief Financial Officer (CFO) and Key Managerial Personnel. His resignation will take effect from August 31, 2026, and is attributed to personal reasons. At the sectoral level, the PSU Bank index advanced 1%, while selling pressure was seen in consumer durables, IT and infrastructure stocks. The broader market remained positive, with both the Nifty Midcap and Nifty Smallcap indices gaining around 0.3% each.

See More
DEEPAK PAL

DEEPAK PAL

28 Jul • 1:28 PM · SEBI-Registered Analyst

IPO UPDATE----> Before You Apply for the Manipal Health IPO, Read This.

One of India's largest healthcare providers, Manipal Health Enterprises, is set to hit the primary market with one of the biggest IPOs of 2026. The company isn't raising capital just to list on the stock exchange—it is preparing for its next phase of expansion in India's rapidly growing healthcare sector. ##IPO Snapshot • IPO Size: ₹9,275 crore • Price Band: ₹560–₹590 per share • IPO Opens: 29 July 2026 • IPO Closes: 31 July 2026 • The issue comprises a fresh issue and an Offer for Sale (OFS). ***** Is This IPO Important? Manipal Health is among India's largest hospital networks, operating: 49 hospitals 13,000+ operational beds Presence across multiple Indian cities with a strong focus on tertiary and quaternary healthcare ------>Where Will the IPO Money Be Used? The company plans to: • Significantly reduce debt • Fund future expansion • Add 2,400–3,000 new beds over the next few years ##Why Could Healthcare Remain a Long-Term Theme? Several structural trends are supporting the sector: • Rising health insurance penetration • Increasing lifestyle diseases • Higher healthcare spending • Growing medical tourism ##Focus Stocks • Manipal Health Enterprises (Upcoming IPO) •

APOLLOHOSP
•
FORTIS
•
NH
•
MAXHEALTH
•
RAINBOW
----->Bottom Line Healthcare isn't just becoming a necessity—it's becoming one of India's biggest long-term growth industries. With an expanding hospital network, aggressive capacity addition, and a strategy to strengthen its balance sheet, Manipal Health is entering the public markets at a time when demand for quality healthcare continues to grow.

See More

News & Events

Frequently Asked Questions

What is the share price of Rainbow Children's Medicare Ltd.?

What is the market cap of Rainbow Children's Medicare Ltd.?

Should I buy Rainbow Children's Medicare Ltd. stock now?

What is the 52 week high and low of Rainbow Children's Medicare Ltd.?

Is the Rainbow Children's Medicare Ltd. stock good to buy?

Is Rainbow Children's Medicare Ltd. a good buy for the long term?

Is Rainbow Children's Medicare Ltd. overvalued or undervalued?

What is the PE and PB ratio of Rainbow Children's Medicare Ltd.?

Start Now